07/06/2026
📊 Research Summary: Finerenone slowed eGFR decline, reduced albuminuria, and lowered risk of kidney failure or ≥40% eGFR decline in adults with chronic kidney disease ( ) due to glomerular diseases, with similar safety profile to placebo.
https://ja.ma/49H7fXq